Purow B - Search Results

1

Data-Driven Computational Modeling Identifies Determinants of Glioblastoma Response to SHP2 Inhibition.

Day EK, Zhong Q, Purow B, Lazzara MJ. Day EK, et al. Among authors: purow b. Cancer Res. 2021 Apr 15;81(8):2056-2070. doi: 10.1158/0008-5472.CAN-20-1756. Epub 2021 Feb 11. Cancer Res. 2021. PMID: 33574084 Free PMC article.

2

microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma.

Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S, Purow B. Kefas B, et al. Among authors: purow b. Cancer Res. 2008 May 15;68(10):3566-72. doi: 10.1158/0008-5472.CAN-07-6639. Cancer Res. 2008. PMID: 18483236

3

MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.

Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, Johnson E, Marcinkiewicz L, Jiang J, Yang Y, Schmittgen TD, Lopes B, Schiff D, Purow B, Abounader R. Li Y, et al. Among authors: purow b. Cancer Res. 2009 Oct 1;69(19):7569-76. doi: 10.1158/0008-5472.CAN-09-0529. Epub 2009 Sep 22. Cancer Res. 2009. PMID: 19773441 Free PMC article.

4

Hepatocyte growth factor sensitizes brain tumors to c-MET kinase inhibition.

Zhang Y, Farenholtz KE, Yang Y, Guessous F, Dipierro CG, Calvert VS, Deng J, Schiff D, Xin W, Lee JK, Purow B, Christensen J, Petricoin E, Abounader R. Zhang Y, et al. Among authors: purow b. Clin Cancer Res. 2013 Mar 15;19(6):1433-44. doi: 10.1158/1078-0432.CCR-12-2832. Epub 2013 Feb 5. Clin Cancer Res. 2013. PMID: 23386689 Free PMC article.

5

microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma.

Kim J, Zhang Y, Skalski M, Hayes J, Kefas B, Schiff D, Purow B, Parsons S, Lawler S, Abounader R. Kim J, et al. Among authors: purow b. Cancer Res. 2014 Mar 1;74(5):1541-53. doi: 10.1158/0008-5472.CAN-13-1449. Epub 2014 Jan 14. Cancer Res. 2014. PMID: 24425048 Free PMC article.

6

Molecular Pathways: Targeting Diacylglycerol Kinase Alpha in Cancer.

Purow B. Purow B. Clin Cancer Res. 2015 Nov 15;21(22):5008-12. doi: 10.1158/1078-0432.CCR-15-0413. Epub 2015 Sep 29. Clin Cancer Res. 2015. PMID: 26420856 Free PMC article.

7

Combined CDK4/6 and mTOR Inhibition Is Synergistic against Glioblastoma via Multiple Mechanisms.

Olmez I, Brenneman B, Xiao A, Serbulea V, Benamar M, Zhang Y, Manigat L, Abbas T, Lee J, Nakano I, Godlewski J, Bronisz A, Abounader R, Leitinger N, Purow B. Olmez I, et al. Among authors: purow b. Clin Cancer Res. 2017 Nov 15;23(22):6958-6968. doi: 10.1158/1078-0432.CCR-17-0803. Epub 2017 Aug 16. Clin Cancer Res. 2017. PMID: 28814434 Free PMC article.

8

Combined c-Met/Trk Inhibition Overcomes Resistance to CDK4/6 Inhibitors in Glioblastoma.

Olmez I, Zhang Y, Manigat L, Benamar M, Brenneman B, Nakano I, Godlewski J, Bronisz A, Lee J, Abbas T, Abounader R, Purow B. Olmez I, et al. Among authors: purow b. Cancer Res. 2018 Aug 1;78(15):4360-4369. doi: 10.1158/0008-5472.CAN-17-3124. Epub 2018 May 29. Cancer Res. 2018. PMID: 29844123 Free PMC article.

9

Glioblastoma Cell Resistance to EGFR and MET Inhibition Can Be Overcome via Blockade of FGFR-SPRY2 Bypass Signaling.

Day EK, Sosale NG, Xiao A, Zhong Q, Purow B, Lazzara MJ. Day EK, et al. Among authors: purow b. Cell Rep. 2020 Mar 10;30(10):3383-3396.e7. doi: 10.1016/j.celrep.2020.02.014. Cell Rep. 2020. PMID: 32160544 Free PMC article.

10

ERK-dependent suicide gene therapy for selective targeting of RTK/RAS-driven cancers.

Day EK, Campbell A, Pandolf A, Rogerson T, Zhong Q, Xiao A, Purow B, Lazzara MJ. Day EK, et al. Among authors: purow b. Mol Ther. 2021 Apr 7;29(4):1585-1601. doi: 10.1016/j.ymthe.2020.12.019. Epub 2020 Dec 15. Mol Ther. 2021. PMID: 33333291 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page